Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age
Details
Publication Year 2024,Volume 16,Issue #1,Page 6-11
Journal Title
Journal of Contemporary Brachytherapy
Publication Type
Research article
Abstract
PURPOSE: Low-dose-rate (LDR) brachytherapy in young men remains controversial amongst urologists due to their concerns regarding long-term biochemical control and treatment-related toxicities. The purpose of this study was to evaluate the treatment outcomes of men under 60 years of age who underwent LDR brachytherapy with iodine-125 ((125)I) for clinically localized low- to intermediate-risk prostate cancer. MATERIAL AND METHODS: All consecutive patients with clinically localized prostate cancer treated at our institution from 2003 to 2016 with (125)I monotherapy were included in the study. Prescription dose was 145.0 Gy modified peripheral loading (MPD). All patients were assessed for biochemical progression-free survival using Phoenix definition (nadir +2 ng/ml), clinical progression-free survival, overall survival (OS), and any associated treatment toxicity. RESULTS: A total of 161 patients were included, with a median follow-up of 6.8 years (range, 3-14.54 years). Median age at implant was 57 years (range, 53-59 years). Mean prostate specific antigen (PSA) level at diagnosis was 4.43 ng/ml (SD = 2.29). Majority of men had low-risk prostate cancer (70.2%). Biochemical progression-free survival at 8 years was 94% for the entire cohort. Median PSA at 4 years was 0.169 (IQR, 0.096-0.360), with 45% of patients having a PSA greater than 0.2. OS was 96.9%, with 5 deaths reported but only one was secondary to prostate cancer. Late grade > 2 genitourinary toxicities were reported in 18 patients (11.2%). Three patients (1.9%) developed secondary cancers, all considered unrelated to their LDR brachytherapy. CONCLUSIONS: With excellent long-term treatment outcomes and minimal associated toxicities, our results showed that LDR brachytherapy can be an effective treatment of choice in younger men.
Department(s)
Radiation Oncology
PubMed ID
38584883
Open Access at Publisher's Site
https://doi.org/10.5114/jcb.2024.135630
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-08-20 03:41:51
Last Modified: 2024-08-20 06:57:07

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙